Fabian Hausmann

Fabian Hausmann

Auto-generated profile, based on publicly available information

Fabian Hausmann

Institute of Medical Systems Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Science Immunology
Verified
Journal Article
Open access
PDF file
YZYu Zhao
Yu Zhao
CKChristoph Kilian
Christoph Kilian
JTJan-Eric Turner
Jan-Eric Turner
LBLidia Bosurgi
Lidia Bosurgi
KRKevin Roedl
Kevin Roedl
CKChristian F. Krebs
Christian F. Krebs
Tissue-resident memory-like T H 17 cells are clonally expanded in bronchoalveolar lavage fluid of patients with severe COVID-19.

17 May 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
RDRichard Drexler
Richard Drexler
RKRobin Khatri
Robin Khatri
TSThomas Sauvigny
Thomas Sauvigny
MMMalte Mohme
Malte Mohme
CMCecile L. Maire
Cecile L. Maire
FRFranz Ricklefs
Franz Ricklefs
Neural–tumor interactions drive glioma growth as evidenced in preclinical models, but clinical validation is limited. We present an epigenetically defined neural signature of glioblastoma that independently predicts patients’ survival. We use reference signatures of neural cells to deconvolve tumor DNA and classify samples into low- or high-neural tumors. High-neural glioblastomas exhibit hypomethylated CpG sites and upregulation of genes associated with synaptic integration. Single-cell transcriptomic analysis reveals a high abundance of malignant stemcell-like cells in high-neural glioblastoma, primarily of the neural lineage. These cells are further classified as neural-progenitor-cell-like, astrocyte-like and oligodendrocyte-progenitor-like, alongside oligodendrocytes and excitatory neurons. In line with these findings, high-neural glioblastoma cells engender neuron-to-glioma synapse formation in vitro and in vivo and show an unfavorable survival after xenografting. In patients, a high-neural signature is associated with decreased overall and progression-free survival. High-neural tumors also exhibit increased functional connectivity in magnetencephalography and resting-state magnet resonance imaging and can be detected via DNA analytes and brain-derived neurotrophic factor in patients’ plasma. The prognostic importance of the neural signature was further validated in patients diagnosed with diffuse midline glioma. Our study presents an epigenetically defined malignant neural signature in high-grade gliomas that is prognostically relevant. High-neural gliomas likely require a maximized surgical resection approach for improved outcomes.

7 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LGLucas Caldi Gomes
Lucas Caldi Gomes
SHSonja Hänzelmann
Sonja Hänzelmann
FHFabian Hausmann
Fabian Hausmann
RKRobin Khatri
Robin Khatri
SOSergio Oller
Sergio Oller
Paul LingorPaul Lingor
Paul Lingor
Amyotrophic lateral sclerosis (ALS) is a debilitating motor neuron disease and lacks effective disease-modifying treatments. This study utilizes a comprehensive multiomic approach to investigate the early and sex-specific molecular mechanisms underlying ALS. By analyzing the prefrontal cortex of 51 patients with sporadic ALS and 50 control subjects, alongside four transgenic mouse models (C9orf72-, SOD1-, TDP-43-, and FUS-ALS), we have uncovered significant molecular alterations associated with the disease. Here, we show that males exhibit more pronounced changes in molecular pathways compared to females. Our integrated analysis of transcriptomes, (phospho)proteomes, and miRNAomes also identified distinct ALS subclusters in humans, characterized by variations in immune response, extracellular matrix composition, mitochondrial function, and RNA processing. The molecular signatures of human subclusters were reflected in specific mouse models. Our study highlighted the mitogen-activated protein kinase (MAPK) pathway as an early disease mechanism. We further demonstrate that trametinib, a MAPK inhibitor, has potential therapeutic benefits in vitro and in vivo, particularly in females, suggesting a direction for developing targeted ALS treatments.

2 January 2024 in GigaScience
Verified
Journal Article
Open access
FHFabian Hausmann
Fabian Hausmann
LGLucas Caldi Gomes
Lucas Caldi Gomes
SHSonja Hänzelmann
Sonja Hänzelmann
RKRobin Khatri
Robin Khatri
SOSergio Oller
Sergio Oller
Paul LingorPaul Lingor
Paul Lingor
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, which still lacks effective disease-modifying therapies. Similar to other neurodegenerative disorders, such as Alzheimer and Parkinson disease, ALS pathology is presumed to propagate over time, originating from the motor cortex and spreading to other cortical regions. Exploring early disease stages is crucial to understand the causative molecular changes underlying the pathology. For this, we sampled human postmortem prefrontal cortex (PFC) tissue from Brodmann area 6, an area that exhibits only moderate pathology at the time of death, and performed a multiomic analysis of 51 patients with sporadic ALS and 50 control subjects. To compare sporadic disease to genetic ALS, we additionally analyzed PFC tissue from 4 transgenic ALS mouse models (C9orf72-, SOD1-, TDP-43-, and FUS-ALS) using the same methods. This multiomic data resource includes transcriptome, small RNAome, and proteome data from female and male samples, aimed at elucidating early and sex-specific ALS mechanisms, biomarkers, and drug targets.

16 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LGLucas Caldi Gomes
Lucas Caldi Gomes
SHSonja Hänzelmann
Sonja Hänzelmann
FHFabian Hausmann
Fabian Hausmann
RKRobin Khatri
Robin Khatri
SOSergio Oller
Sergio Oller
Paul LingorPaul Lingor
Paul Lingor
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease and lacks effective disease-modifying treatments. Here, we performed a multiomic analysis of the prefrontal cortex of 51 patients with sporadic ALS and 50 control subjects, as well as four transgenic mouse models of C9orf72-, SOD1-, TDP-43-, and FUS-ALS to characterize early and sex-specific disease mechanisms in ALS. Integrated analyses of transcriptomes, (phospho)proteomes, and miRNAomes revealed more pronounced changes in males. We identified transcriptome-based human ALS subclusters driven by the immune response, ECM, mitochondrial respiration, and RNA metabolism. The molecular signatures of human subclusters were reflected in specific mouse models. Individual and integrative multiomics analysis highlighted the mitogen-activated protein kinase pathway as an early disease-relevant mechanism. Its modulation by trametinib in vitro and in vivo validated that mitogen-activated protein kinase kinase 2 is a promising therapeutic target with beneficial effects in females.

1 November 2024 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
SGSydney E. Gies
Sydney E. Gies
SHSonja Hänzelmann
Sonja Hänzelmann
DKDominik Kylies
Dominik Kylies
MLMoritz Lassé
Moritz Lassé
SLSimon Lagies
Simon Lagies
THTobias B. Huber
Tobias B. Huber
In this study, we addressed challenges in integrating clinically obtained kidney biopsies into everyday clinical routines. Using porcine kidneys, we evaluated preservation media (RNAlater and CellCover) versus snap freezing for multi-omics processing. Our analyses highlighted RNAlater’s suitability for single-nucleus RNA sequencing, proteome analysis and histopathological evaluation. Only metabolomics are currently restricted to snap-frozen biopsies. Our research established a cryopreservation protocol that facilitates tissue biobanking for advancing precision medicine in nephrology.